Ivermectin and Kidney Function: Is There a Risk?
Written by Dr. Daniel Foster, Men's Health, Urology & Sexual Wellness Content Specialist
Reviewed for medical accuracy under the Ivermectinkart Editorial Policy
Introduction
If you have kidney disease or reduced kidney function, it is reasonable to wonder whether a medicine such as ivermectin could place extra strain on your kidneys. The available evidence on ivermectin and kidney function is generally reassuring because the kidneys are not the main route by which ivermectin leaves the body. Ivermectin is processed mainly in the liver, and most of the drug and its metabolites are eliminated through the faeces, while less than 1% of a dose is excreted in urine. This means reduced kidney function is less likely to substantially alter ivermectin exposure than it would for a medicine cleared mainly through urine. However, direct studies in people with advanced kidney disease are limited, so kidney problems should not be treated as irrelevant. This article explains what is known, where evidence is limited, and when people with kidney disease should seek medical advice before taking ivermectin.
Ivermectin and Kidney Function: How Is the Drug Cleared?
Ivermectin depends much more on liver metabolism and faecal elimination than on the kidneys.
According to current official ivermectin prescribing information , ivermectin is metabolised in the liver, and ivermectin or its metabolites are excreted almost entirely in the faeces over an estimated 12 days; less than 1% of the administered dose is excreted in urine.
That distinction matters because medicines eliminated primarily through the kidneys can accumulate when kidney filtration falls. Ivermectin does not appear to depend heavily on this pathway.
What happens after you take oral ivermectin?
After oral administration, ivermectin enters the bloodstream and reaches peak concentrations within several hours. Its plasma half-life—the approximate time needed for the blood concentration to fall by half—is about 18 hours according to current US prescribing information.
The liver transforms ivermectin into metabolites, largely through the CYP3A4 enzyme system. Older human pharmacokinetic research also found that ivermectin and its metabolites are eliminated predominantly through faeces rather than urine.
How the liver and kidneys differ in ivermectin handling
Part of the body | Role in ivermectin handling | Why it matters |
Liver | Major site of ivermectin metabolism | Liver function and certain interacting medicines may influence ivermectin exposure |
Digestive/biliary system | Major pathway leading to elimination in faeces | Most ivermectin does not leave the body through urine |
Kidneys | Minor elimination pathway | Less than 1% of an administered dose is reported in urine |
Urine | Contains only a small proportion of the administered dose | Reduced kidney filtration would not be expected to affect ivermectin like it affects primarily renally cleared drugs |
Ivermectin is not primarily cleared by the kidneys. That makes substantial drug accumulation from reduced kidney filtration less likely, but it does not prove that every person with chronic kidney disease or kidney failure can use ivermectin without additional medical assessment.
Does Ivermectin Damage the Kidneys?
At standard human treatment doses, direct kidney toxicity is not established as a typical ivermectin adverse effect. Current US prescribing information lists gastrointestinal, neurological, skin, cardiovascular and other reactions, but kidney injury is not listed among the commonly reported treatment-related adverse reactions or the postmarketing reactions presented in that label.
That does not mean kidney complications are impossible. Medical evidence can rarely establish that a medicine carries absolutely zero risk, particularly in patients with serious underlying illness, dehydration, multiple medications or unusually high exposures.
What about reports of acute kidney injury?
There are isolated reports involving renal problems in unusual clinical circumstances, but these should not be interpreted as evidence that ordinary prescribed ivermectin commonly damages healthy kidneys.
For example, a 1997 case report described severe renal impairment after ivermectin in a patient with Loa loa filarial infection. A single case cannot establish how frequently an event occurs or prove that ivermectin itself was the sole cause.
A 2026 report described acute kidney injury and thrombotic microangiopathy after ingestion of a very large quantity of an avermectin pesticide preparation. That poisoning scenario is fundamentally different from taking an appropriately prescribed human ivermectin product.
Can You Take Ivermectin if You Have Kidney Disease?
Having kidney disease does not automatically mean ivermectin cannot be used. Because only a very small proportion of ivermectin is eliminated through urine, pharmacokinetic reviews have concluded that significant changes in exposure from renal impairment would not generally be expected. However, dedicated evidence in people with severe chronic kidney disease or kidney failure remains limited.
For that reason, someone with chronic kidney disease should not independently decide that a standard dose is automatically appropriate. The reason for treatment, kidney function, other illnesses and other medicines still need to be considered.
Is a kidney-based dose reduction required?
There is no well-established general renal dose-adjustment schedule for ivermectin comparable with those used for strongly kidney-cleared medicines.
A human ivermectin pharmacokinetics review notes that only about 1% of ivermectin is eliminated through urine. Another pharmacokinetic review concluded that renal dose adjustment would not appear necessary on the basis of this low renal excretion, while also acknowledging that information in patients with impaired kidney function is limited.
This is an important distinction: “dose adjustment does not appear necessary” is not the same as “severe kidney disease has been extensively studied.”
Does Reduced Kidney Function Change Ivermectin Levels?
Probably not to a major extent based on ivermectin's known elimination pathway, but the evidence is less complete than it is for many commonly used medicines. Since the kidneys eliminate only a small proportion of a dose, worsening kidney filtration would not be expected to dramatically reduce total ivermectin clearance.
What about severe kidney failure or dialysis?
Evidence is particularly limited for people with end-stage kidney disease or those receiving dialysis. Standard prescribing information does not provide a well-defined dialysis-specific ivermectin dosing regimen.
People receiving dialysis frequently take several medicines and may have significant changes in fluid balance, blood pressure, protein levels and other aspects of health. Those factors provide additional reasons for ivermectin treatment to be reviewed by the treating clinician rather than self-managed.
Practical ivermectin precautions for people with reduced kidney function
Do | Don't |
Tell the prescriber if you have chronic kidney disease or receive dialysis | Assume kidney disease makes every usual ivermectin regimen automatically safe |
Provide an up-to-date medication list | Combine ivermectin with additional medicines without checking for interactions |
Use a human formulation prescribed or recommended for the intended condition | Use veterinary ivermectin products |
Follow the prescribed amount and treatment schedule | Take extra or repeated doses in an attempt to improve effectiveness |
Seek advice if vomiting or diarrhoea becomes significant | Ignore persistent fluid loss, especially if you have kidney or heart disease |
Ask whether kidney tests need monitoring based on your overall medical condition | Order or interpret kidney tests as a substitute for clinical assessment |
What Can Increase Kidney Risk Around Ivermectin Treatment?
The bigger concern may sometimes be the person's overall medical situation rather than direct toxicity from ivermectin itself. Kidney function can deteriorate when illness, fluid loss, low blood pressure or other kidney-affecting medicines occur at the same time.
Dehydration from vomiting or diarrhoea
Nausea, vomiting and diarrhoea are among the gastrointestinal adverse reactions reported with oral ivermectin.
For most people these symptoms do not mean kidney injury is occurring. But significant vomiting or diarrhoea can lead to dehydration, and dehydration can reduce blood flow to the kidneys—particularly in older adults and people who already have chronic kidney disease, heart disease or limited fluid reserves.
Low blood pressure
Orthostatic hypotension—blood pressure falling when standing—has been reported with ivermectin treatment, particularly in clinical experience involving onchocerciasis.
Severe or prolonged low blood pressure can compromise kidney perfusion. This is not evidence that ivermectin directly poisons the kidneys, but it explains why symptoms such as fainting, marked weakness or persistent dizziness should not simply be ignored.
Other medicines
People with chronic kidney disease often take medicines for high blood pressure, diabetes, fluid retention, cardiovascular disease or other conditions. Some combinations may require closer monitoring during an acute illness, particularly when vomiting, diarrhoea or reduced fluid intake develops.
Ivermectin also has recognised drug-interaction considerations. Current prescribing information, for example, reports rare increases in INR when ivermectin has been taken with warfarin.
Should Kidney Function Be Tested Before or After Ivermectin?
Routine kidney testing is not automatically necessary for every otherwise healthy person receiving a standard prescribed course of ivermectin. Testing becomes more relevant when someone already has chronic kidney disease, has recently experienced worsening kidney function, takes several medicines, is dehydrated, or has symptoms suggesting an acute medical problem.
Common measurements include serum creatinine and estimated glomerular filtration rate, or eGFR. These help clinicians assess how effectively the kidneys are filtering the blood.
A clinician may also consider electrolytes such as potassium and sodium when there has been substantial vomiting, diarrhoea, dehydration or another illness that can disturb fluid and mineral balance.
Kidney tests should be interpreted in context. A change in creatinine during an illness does not by itself prove that ivermectin caused the problem.
When Should You Seek Medical Care?
Seek prompt medical advice if you have kidney disease and develop persistent vomiting or diarrhoea, significantly reduced urine output, new swelling, fainting, severe weakness, confusion or difficulty maintaining fluid intake after taking any medicine.
Urgent assessment is also appropriate after taking substantially more ivermectin than prescribed or after ingesting a veterinary formulation. The FDA ivermectin safety information warns that large doses can be dangerous and that veterinary products should not be used as substitutes for medicines formulated for humans.
People receiving dialysis, those with advanced chronic kidney disease, and patients taking several prescription medicines should discuss ivermectin with their treating clinician or pharmacist before use. The same applies if the intended use has not been established as an appropriate treatment for the condition being treated.
Conclusion
The evidence on ivermectin and kidney function suggests that the kidneys play only a minor role in clearing the medicine: less than 1% of an administered dose is reported in urine, while metabolism and faecal elimination account for most clearance. Direct kidney toxicity is not established as a common effect of standard prescribed ivermectin, but evidence in severe kidney impairment and dialysis remains limited. If you have chronic kidney disease, do not alter or repeat ivermectin doses on your own. Ask your doctor or pharmacist to review the indication, formulation, other medicines and whether kidney monitoring is appropriate for you.
Frequently Asked Questions
1. Is ivermectin hard on your kidneys?
Ivermectin is not considered primarily kidney-cleared, and direct kidney toxicity is not established as a common effect of usual prescribed treatment. Less than 1% of a dose is excreted in urine. Individual risk can still differ when kidney disease or other illnesses are present.
2. Can someone with chronic kidney disease take ivermectin?
Kidney disease does not automatically rule out ivermectin because renal elimination is minimal. However, people with chronic kidney disease should have treatment reviewed by a clinician, especially when disease is advanced, other medicines are involved, or kidney function is unstable.
3. Does ivermectin require a lower dose when kidney function is reduced?
There is no standard kidney-based ivermectin dose-reduction schedule supported by strong clinical evidence. Its very low urinary excretion suggests renal impairment has limited effect on clearance. Severe kidney impairment and dialysis have not been as thoroughly studied.
4. Can ivermectin raise creatinine levels?
A predictable rise in serum creatinine is not described as a typical ivermectin effect in current prescribing information. If creatinine rises during treatment, clinicians should consider dehydration, underlying illness, other medicines and kidney disease rather than assuming ivermectin is automatically responsible.
5. Can a person on dialysis take ivermectin?
Evidence specifically addressing ivermectin in dialysis patients is limited, and there is no established universal dialysis-specific dosing recommendation. Because these patients often have complex health conditions and medication regimens, ivermectin should be reviewed by their treating clinician or pharmacist before use.
6. Should I drink extra water while taking ivermectin to protect my kidneys?
There is no evidence that deliberately drinking excessive amounts of water makes ivermectin safer for the kidneys. Normal hydration is generally sensible, but some people with kidney or heart disease have fluid restrictions. Follow the fluid advice given by your healthcare team.
Comments